OALib Journal期刊
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
DOI: 10.1634/theoncologist.2015-0497
Alexa B. Schrock ,
Atul Kulkarni ,
Doron Lipson ,
Eric Sanford ,
Garrett M. Frampton ,
Heather Wakelee ,
Heber MacMahon ,
James H. Suh ,
Jan Nowak ,
Jeffrey S. Ross ,
Jie He ,
Julia A. Elvin ,
Julian R. Molina ,
Juliann Chmielecki ,
Julie R. Brahmer ,
Justin Allen ,
Kashif Firozvi ,
Kyle Gowen ,
Marc Ladanyi ,
Marjorie Zauderer ,
Maureen Zakowski ,
Neil Fischbach ,
Nir Peled ,
Phil J. Stephens ,
Ravi Salgia ,
Roman Yelensky ,
Sai-Hong Ignatius Ou ,
Samuel J. Klempner ,
Shridar Ganesan ,
Siraj M. Ali ,
Smitha Menon ,
Thomas Hensing ,
Vincent A. Miller ,
Zachary Chalmers Keywords: ALK , Crizotinib , Fluorescence in situ hybridization , Genomic profiling , Fusion
Abstract:
Full-Text
Contact Us
service@oalib.com
QQ:3279437679
WhatsApp +8615387084133
